Widera, Willham, and Harper Help Launch New AGS Curriculum on Alzheimer’s Diagnostics and Treatments

Eric Widera, MD, and Kaitlin Willham, MD, co-authored the module "Evidence Review of FDA-Approved Monoclonal Antibody Treatments," as part of the newly published AGS online curriculum, "Alzheimer's Disease: New Diagnostic Technologies and Treatments." Th curriculum was developed to educate health professionals on the evolving landscape of Alzheimer's disease diagnosis and treatment and to support meaningful conversations with patients and their care partners.  Michael Harper, MD, served as the curriculum editor. It is available to AGS members at https://geriatricscareonline.org/toc/Alzheimers-Curriculum/OC007/.